VN

Vanita Narula

Director Director DIN 07993852
DIN 07993852 First appointment Mar 2018 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Vanita Narula

Data last updated:

Vanita Narula was a Director at Dr. Wellmans Homoeopathic Laboratory (India) Private Limited (2018–2024) and Director at Dr. Wolfe Dietri Herbals Private Limited (from 2018). The companies operate in Pharma.

DIN 07993852
Primary Designation Director
Industry Pharma
First Appointment 28 Mar 2018
Oldest Company Age 15 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Mar 20182011₹2.71 Cr (FY 2024)Active
Director28 Mar 20182011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dr. Wolfe Dietri Herbals Private Limited
Dr. Wellmans Homoeopathic Laboratory (India) Private Limited
Premium access

Shareholding and investment profile for Vanita Narula

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vanita Narula

Vanita Narula was first appointed on 28 Mar 2018 as Director at Dr. Wellmans Homoeopathic Laboratory (India) Private Limited.

Vanita Narula held 2 earlier board appointments: Dr. Wellmans Homoeopathic Laboratory (India) Private Limited (Director, 28 Mar 2018 to 01 Aug 2024); Dr. Wolfe Dietri Herbals Private Limited (Director, from 28 Mar 2018).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available